XML 87 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
 3 Months Ended
Jun. 29, 2013
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION
Segment Definition Criteria

We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product categories.

Enterprise-Wide Disclosures about Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.
Our products include whole blood disposables, equipment devices and the related disposables used with these devices. Disposables include part of plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals. Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients as well as disposables for manual whole blood collection. Hospital consists of surgical disposables (principally the Cell Saver® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT® cardiovascular perioperative autotransfusion system designed to remain with the patient following surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG® Thrombelastograph® hemostasis analyzer used to help assess a surgical patient’s hemostasis during and after surgery). Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.
Revenues from External Customers:
 
Three Months Ended
(In thousands)
June 29,
2013
 
June 30,
2012
Disposable revenues
 
 
 
Plasma disposables
$
65,336

 
$
63,878

Blood center disposables
 
 
 
Platelet
34,446

 
37,242

Red cell
10,009

 
12,068

            Whole blood
51,254

 
—

 
95,709

 
49,310

Hospital disposables
 
 
 
Surgical
16,089

 
18,260

OrthoPAT
6,320

 
7,541

Diagnostics
7,594

 
6,499

 
30,003

 
32,300

Disposables revenue
191,048

 
145,488

Software solutions
16,746

 
17,304

Equipment & other
11,749

 
13,683

Net revenues
$
219,543

 
$
176,475